Infertility Clinical Trial
Official title:
Molecular Markers of Human Sperm Function
Objectives:
Male factor infertility is poorly understood and our ability to evaluate the male
contribution to a couple's infertility is very limited. The overarching goal of this project
is to understand at the molecular level what functional activities in human sperm are
required for successful fertilization leading to full term development. These findings will
allow us to develop new methods to determine the impact of environmental exposures on sperm
quality and male fertility.
A sperm protein known as phospholipase C zeta (PLC zeta) initiates embryo development at
fertilization. The primary objective of this study is to test the hypothesis that human PLC
zeta activity correlates directly with the proportion of fertilized eggs that undergo early
cleavage during an in vitro fertilization (IVF) cycle. Secondary objectives for the study
are to generate preliminary data regarding the variability in sperm PLC zeta activity within
and between individuals and to determine if there are clinical or laboratory correlates for
sperm PLC zeta activity.
Study population:
The study population will consist of 178 infertile couples undergoing IVF procedures at Duke
Fertility Center (DFC) from which we will obtain 154 evaluable couples for the study.
Overall Design:
An observational cohort study design will be used to assess the association of PLC zeta
activity in the residual sperm from the sample used for an IVF cycle with the proportion of
eggs per couple that undergo early cleavage during the same cycle. Infertile couples
enrolling in an IVF treatment cycle at DFC will be approached for inclusion in the study.
Consent will be obtained from both male and female partners, and historical medical
information and information about their IVF cycle will be collected by chart review. Blood
for isolation of serum and DNA will be collected only from the male partner for evaluation
of hormone levels and genetic analyses related to infertility. On the day of the egg
retrieval, residual sperm not needed for clinical purposes will be transported via courier
to NIEHS. Sperm PLC zeta activity will be measured in the investigator's laboratory using an
experimental bioassay. Sperm PLC zeta protein will be analyzed at the University of
Massachusetts.
Outcome Parameters:
The primary outcome will be the proportion of embryos that undergo early cleavage. Secondary
outcomes will include proportion of eggs fertilized, embryo development parameters, and p...
Objectives:
Male factor infertility is poorly understood and our ability to evaluate the male
contribution to a couple's infertility is very limited. The overarching goal of this project
is to understand at the molecular level what functional activities in human sperm are
required for successful fertilization leading to full term development. These findings will
allow us to develop new methods to determine the impact of environmental exposures on sperm
quality and male fertility.
A sperm protein known as phospholipase C zeta (PLC zeta) initiates embryo development at
fertilization. The primary objective of this study is to test the hypothesis that human PLC
zeta activity correlates directly with the proportion of fertilized eggs that undergo early
cleavage during an in vitro fertilization (IVF) cycle. Secondary objectives for the study
are to generate preliminary data regarding the variability in sperm PLC zeta activity within
and between individuals and to determine if there are clinical or laboratory correlates for
sperm PLC zeta activity.
Study population:
The study population will consist of 178 infertile couples undergoing IVF procedures at Duke
Fertility Center (DFC) from which we will obtain 154 evaluable couples for the study.
Overall Design:
An observational cohort study design will be used to assess the association of PLC zeta
activity in the residual sperm from the sample used for an IVF cycle with the proportion of
eggs per couple that undergo early cleavage during the same cycle. Infertile couples
enrolling in an IVF treatment cycle at DFC will be approached for inclusion in the study.
Consent will be obtained from both male and female partners, and historical medical
information and information about their IVF cycle will be collected by chart review. Blood
for isolation of serum and DNA will be collected only from the male partner for evaluation
of hormone levels and genetic analyses related to infertility. On the day of the egg
retrieval, residual sperm not needed for clinical purposes will be transported via courier
to NIEHS. Sperm PLC zeta activity will be measured in the investigator's laboratory using an
experimental bioassay. Sperm PLC zeta protein will be analyzed at the University of
Massachusetts.
Outcome Parameters:
The primary outcome will be the proportion of embryos that undergo early cleavage. Secondary
outcomes will include proportion of eggs fertilized, embryo development parameters, and
pregnancy outcome. Association of PLC zeta activity with male partner's clinical or
laboratory information will be determined. Variability in sperm PLC zeta activity will be
determined within and between individuals.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A |